According to a new report LAMEA Burn Ointment Market, published by KBV research, the LAMEA Burn Ointment Market would witness market growth of 6.6% CAGR during the forecast period (2020-2026).
The Brazil market dominated the LAMEA Iodine Market by Country in 2019, thereby, achieving a market value of $7 Million by 2026. The Argentina market would witness a CAGR of 7.4% during (2020 - 2026). Additionally, The UAE market is showcasing a CAGR of 6.5% during (2020 - 2026).
The Minor Burns market dominated the Saudi Arabia Burn Ointment Market by Depth of Burn in 2019, growing at a CAGR of 6.6 % during the forecast period. The Partial Thickness Burns market is exhibiting a CAGR of 7.3% during (2020 - 2026).
The Hospitals market dominated the South Africa Burn Ointment Market by End Use in 2019, growing at a CAGR of 7 % during the forecast period. The Clinics market is estimated to grow at a CAGR of 7.6% during (2020 - 2026). The Other End Use market is expected to witness a CAGR of 8.2% during (2020 - 2026).
Full Report: https://www.kbvresearch.com/lamea-burn-ointment-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Johnson and Johnson, ConvaTec Group PLC, Smith & Nephew PLC, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Perrigo Company PLC, Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Morepen Limited and Mankind Pharma Ltd.
By Depth of Burn
By Product
By End Use
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
